The global wound care market size was estimated at USD 22.25 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.17% from 2024 to 2030. The demand for wound care products is increasing owing to the increasing number of surgical cases and the rising prevalence of chronic diseases across the globe. Furthermore, the increasing incidence of diabetes due to a sedentary lifestyle is one of the leading factors contributing to market growth. For instance, as per a report by Centers for Disease Control and Prevention (CDC), which was last reviewed in April 2023, 37.3 million Americans have diabetes. Similarly, as per the same source, 96 million American adults have prediabetes.
Besides, wound care products help cure diabetic foot ulcers, which are prevalent in diabetic patients. For instance, according to a National Institute of Health (NIH) report, last updated in August 2023, diabetes is a major cause of non-traumatic amputations in the U.S. Overall, 5% of patients with diabetes develop foot ulcers, of which 1% may need an amputation. Wound care products such as hydrocolloid dressings help in moisture retention and allow rapid healing of wounds internally as well as externally. Moreover, these products help in the absorption of necrotic tissues, which are effective in cases of surgical site infections. Thus, healthcare professionals prefer to use wound care products, which is anticipated to propel the market growth over the forecast period.
Moreover, rising cases of burn injuries are another key factor fueling the market growth. One of the key factors responsible for its dominance is an increase in the number of burn cases. For instance, here are some general statistics on burn injuries based on data from the World Health Organization (WHO) and the American Burn Association:
An estimated 180,000 deaths occur each year worldwide due to burn injuries.
In the U.S., there are approximately 486,000 burn injuries that require medical treatment each year, with about 40,000 of those requiring hospitalization.
In the U.S., fire/flame burns are the most common type of burn injury (43%), followed by scalds (34%), contact burns (9%), electrical burns (4%), chemical burns (3%), and other types of burns (7%).
Furthermore, the increasing number of traumatic injuries globally is expected to propel the market. For instance, according to a WHO report (published in June 2022), around 1.3 million people die every year because of road traffic accidents. Similarly, as per nationgroup.com, in 2022, about 14,737 individuals died in Thailand as a result of traffic-related incidents. Collagenase-based enzymatic wound debridement products are majorly used to treat such acute wounds. Thus, such cases are expected to increase the demand for wound care products.
An increasing number of Ambulatory Surgical Centers (ASCs) are expected to drive the growth of the market. ASCs offer a variety of services, such as surgical care, diagnostics, and preventive procedures. Surgeries for pain management, urology, orthopedics, restorative, reconstructive, or alternative plastic surgeries, and Gastrointestinal (GI) related surgeries are performed in ambulatory surgery centers. In addition, ASCs are increasing in number and thus offer cost-effective services. For instance, as per a report by Blue House Sales Group, in August 2023, there were about 6,179 Medicare-certified ASCs present in the U.S. Thus, with the increasing number of ASCs, the market is expected to grow during the forecast period.
The wound care industry trends are subject to ongoing developments and technological advancements. Continued advancements in wound care technologies, including smart dressings, bioengineered tissues, and digital wound monitoring, offer more sophisticated and effective solutions for wound management. For instance, in January 2023, researchers at the University of Arizona College of Medicine developed a smart bandage combining advanced electronics for accelerating tissue repair. It employs electrical stimulation and biosensors to help enhance blood flow to wounded tissue, close wounds faster, and prevent scar formation.
Furthermore, there is an increasing trend toward developing more environmentally friendly wound care solutions. Concerns about the environmental impact of medical waste, as well as the rising expense of standard wound care solutions, are driving this trend. Biodegradable materials are being used to create interactive wound dressings, minimizing their environmental impact, and increasing sustainability. Thus, the market is expected to witness ongoing collaborations, research endeavors, and the emergence of novel therapies and products aimed at advancing wound healing and patient well-being.
The market growth stage is moderate, with an accelerating pace, characterized by a moderate-to-high degree of growth. Key drivers include the global rising prevalence of chronic and acute wounds, aging population, increasing number of surgeries, and advancements in technology. Regulatory compliance, reimbursement policies, and the trend toward home healthcare also shape the market dynamics. In addition, emerging trends towards tailoring wound care treatments to individual patient characteristics, including genetics and specific wound conditions, are gaining attention, leading to more personalized and targeted interventions.
Key strategies implemented by players in market are new product launches, expansion, acquisitions, partnerships, and other strategies. For instance, in September 2023, MiMedx Group, Inc. launched EPIEFFECT as the newest item in the company’s line of advanced wound care products. EPIEFFECT adds to the firm's core advanced wound care offering for clinicians treating acute and chronic, difficult-to-heal wounds such as diabetic foot ulcers ("DFUs") and venous leg ulcers ("VLUs"), among other ailments. EPIEFFECT has a thick, tri-layer structure that is ideal for suturing the graft in place. Furthermore, its product features and handling characteristics make it an ideal therapy alternative for deep or tunneling wounds.
The market is witnessing a substantial degree of innovation driven by rapid technological advancements and the increasing adoption of advanced products, particularly in home care settings. Home healthcare in the market has gained prominence due to several factors, including the aging population, technological advancements, cost-effectiveness, and the desire for patient-centric care. This shift toward patient-centric care involves developing wound care solutions that are not only effective but also consider patient comfort, ease of use, and the ability for patients to manage aspects of their care independently. In addition, telemedicine and remote monitoring technologies enable healthcare providers to assess and monitor wounds through virtual consultations, reducing the need for frequent hospital or clinic visits.
Regulations play a crucial role in shaping the market, influencing product development, marketing, patient safety, and overall industry practices. Various regulatory bodies and standards such as FDA (Food and Drug Administration) approvals in the United States or CE marking in the European Union oversee the approval and certification of wound care products. Compliance with regulatory standards is essential for market entry and product commercialization. Regulations set stringent quality and safety standards for wound care products. Manufacturers must adhere to Good Manufacturing Practices (GMP) and meet specific criteria to ensure the safety and effectiveness of their products. However, stringent regulatory requirements may act as barriers to entry for smaller companies or new market entrants. Compliance with regulations often involves significant investments in research, testing, and documentation.While compliance with regulatory requirements can pose challenges, it also serves to build trust among healthcare providers, patients, and regulatory authorities, contributing to the overall integrity of the wound care industry.
Companies are actively acquiring development-stage firms to broaden their service portfolios, catering to a larger patient base. Major companies may acquire smaller firms to strengthen their market position, expand product portfolios, or gain access to new technologies. For instance, in April 2023, Convatec Group PLC acquired 30 Technology Limited’s anti-infective nitric oxide technology platform, which includes new product assets and research and development. In addition to its applications in advanced wound care, the firm plans to explore the technical platform for use in other businesses.
The market is highly fragmented and competitive in nature with key players involved in continuous product development & partnership alliances to aid market penetration. Rising number of distributors and dealers is expected to increase industry rivalry in the coming years. Industry players are gaining market penetration via geographical expansion in developing countries.
Companies in the market are strategically focusing on regional expansion to capitalize on emerging opportunities and broaden their market presence. This entails establishing a stronger footprint in key geographical areas through partnerships, acquisitions, and localized marketing strategies. For instance, in April 2021, Mölnlycke Health Care AB expanded its presence in Malaysia with the construction of a new factory. This strategy helped the company establish itself in the Malaysian market. Moreover, by tailoring their products and services to meet regional healthcare needs, wound care firms aim to enhance accessibility and responsiveness, ensuring a more comprehensive and effective market penetration. Thus, regional expansion serves as a critical factor for industry leaders to tap into diverse markets, address specific healthcare demands, and ultimately drive sustained growth.
Based on product, the market has been segmented into advanced wound dressings, surgical wound care, traditional wound care, and wound therapy devices. The advanced wound dressing segment held the maximum share of 34.9% in 2023 in the product segment and is expected to register the highest CAGR during the forecast period. Advanced wound dressing is mainly used to treat chronic and non-healing wounds. Thus, increasing the number of chronic wounds, such as diabetic foot ulcers, is expected to help the wound care industrial propel. For instance, as per the National Center for Biotechnology Information (NCBI), in August 2023, incidence of diabetic foot ulcers globally is between 9.1 million and 26.1 million. In addition, about 15% to 25% of patients with diabetes may develop a diabetic foot ulcer during their lifetime. Therefore, due to the above-mentioned factors, the market is expected to propel during the forecast period.
The surgical wound care segment is anticipated to grow at a considerable growth rate of 4.30% during the forecast period. This can be attributed to rising surgical cases and surgical site infections worldwide. For instance, as per a report by NIH, published in January 2023, around 0.5% to 3% of patients undergoing surgery may experience surgical site infection. Thus, impelling the segment growth.
Chronic wounds segment held the largest share of 59.9% in 2023 and is anticipated to witness a considerable growth rate over the forecast period. An increasing number of geriatric populations, along with the rising prevalence of diabetic foot ulcers, venous pressure ulcers, and other chronic wounds, is expected to drive the segment's growth. For instance, as per a United Health Foundation report (published in May 2023), more than 55.8 million adults aged 65 and older lived in the U.S., accounting for about 16.8% of the nation's population in 2021.
Furthermore, the number of people suffering from varicose vein in the U.S. is increasing year on year. For instance, according to the Journal of the American Heart Association (AHA), approximately 23% i.e., 1 in every 4 U.S. resident have varicose veins. An increase in number of varicose veins may lead to development venous leg ulcers, thus, driving the growth.
Acute wound segment is expected to grow at the fastest CAGR of 4.28% during the forecast period. The increasing number of cases of different traumatic wounds and burns is the major factor driving the segment’s growth. The multiple benefits of acute wound products include reduced surgical site infections, improved results and patient satisfaction, and reduced hospital stays. There is also an increase in the number of burned wounds across the globe. Since acute wound products are majorly used for treating acute wounds such as traumatic wounds, the use of wound care products is expected to help surge the segment growth.
The hospital segment held the largest share of 39.0% in 2023. The growth of this segment can be attributed to an upsurge in surgical procedures globally because of sedentary lifestyle, and rising bariatric surgeries which require the use of wound care products to contain surgical site infections. Furthermore, surgical wound care dressings and negative pressure wound therapy (NPWT) are predominantly suitable for hospital use and are not feasible for home care. In addition, hospital institutions are considered large buyers of wound care having long-term contracts with suppliers. Hence, owing to aforementioned factors, the segment is anticipated to propel during the forecast period.
In addition, the increase in hospital admissions due to surgeries is also anticipated to propel the segment growth over the forecast period. Patients after surgery generally require wound care products to heal from surgical site wounds. Therefore, the segment is expected to witness significant growth over the forecast period.
Home healthcare segment is expected to grow at the fastest CAGR of 5.51% during the forecast period. During the pandemic outbreak, home healthcare wound care products were more in demand. Wound care in homecare settings is majorly initiated with the introduction of single-use NPWT systems. These devices are lightweight, portable, canister-free, and are easy to use. In addition, cost-effectiveness of such therapy for treating wounds also encourages patients to adopt homecare settings over hospital stays.
Moreover, increasing number of geriatric populations is expected to propel the market segment. Geriatric population tends to opt for homecare settings or nursing home care. Furthermore, the presence of several organizations offering home care services in North America and Europe is promoting home care services market. Thus, with an increase in number of geriatric population and nursing home care, the segment is anticipated to impel during the forecast period.
Institutional sales dominated the distribution channel segment. Wound care product manufacturers may also sell products directly to healthcare providers, such as hospitals and clinics, or patients through direct-to-consumer marketing. This approach can provide more control over the distribution process and enable manufacturers to build relationships with their customers. Institutional sales comprise mainly direct distributors and manufacturers. Hospitals, clinics, wound care centers, and other healthcare facilities, such as nursing homes, long-term care facilities, diagnostic laboratories, and birth centers, usually have long-term contracts and tie-ups with distributors and manufacturers. Key players are adopting long-term contracts with end-users as a strategy to expand their reach and strengthen their foothold in the market.
Retail sales are expected to witness the fastest growth in the forecast period, with a CAGR of 4.6%. Retail sales mainly comprise retail pharmacy stores, e-commerce, etc. Customers benefit from pharmacies as they are large in numbers. They offer various delivery options and usually provide good service. Customers typically purchase prescription and non-prescription wound care products at retail pharmacy stores and specialty pharmacies. These pharmacies may stock wound care products such as dressings, ointments, and bandages, and may also provide wound care advice and services. The e-commerce segment is anticipated to expand at the fastest CAGR over the forecast period. Online stores and mail-order companies are quite similar, and their main advantages are cheap prices and ease of access. Rising online and e-commerce accessibility of wound care products will likely aid in market expansion. eHealth is a fast-growing part of e-commerce.
The prescribed segment is anticipated to dominate the market and is projected to grow at a fastest CAGR of 5.0% over the forecast period. The prescribed wound care products depend on the type of product and the severity of the wound. For mild to moderate wounds, over-the-counter wound care products such as bandages, gauze, and antiseptic creams can be purchased at pharmacies, drug stores, or online retailers. For more severe wounds, prescription wound care products such as wound dressings, wound cleansers, and topical antibiotics may be required.
These products can only be obtained with a prescription from a healthcare provider and can be purchased at a pharmacy. Moreover, people are inclined toward prescribed wound care products as Medicare covers around 80% of the cost of medically necessary wound care supplies and surgical dressings. This encourages people to visit physicians and receive prescribed wound care medication.
North America dominated the market with the share of 45.5% in 2023 and is expected to witness the considerable growth rate over the forecast period. Presence of a large population base and, a rising patient pool in countries such as the U.S. are major factors driving the market growth in this region. Moreover, geriatric population is at a higher risk of wounds, this will surge the demand for wound care products in this region. For instance, as per a United Health Foundation report (Published in May 2023), more than 55.8 million adults ages 65 and older live in the U.S., accounting for about 16.8% of the nation's population in 2021. In addition, the increasing number of road accidents, and availability of skilled professionals in this region is expected to drive the demand for wound care products in North America.
Asia Pacific region is estimated to witness the highest growth of CAGR 4.8% in the wound market over the forecast period. Presence of developing economies, such as China, India, and Japan, is anticipated to boost the market in the region. This can be attributed to rising changes in lifestyle leading to an increase in incidence of chronic diseases in this region. In addition, technological advancements, increasing geriatric population, and growing prevalence of chronic diseases, such as diabetes & cancer, are anticipated to boost the regional market. Moreover, medical tourism in this region is contributing to an increase in demand for wound care products. Thus, owing to above mentioned factors, Asia-Pacific is anticipated to witness the fastest growth over the forecast period.
Wound care industry in India is anticipated to grow at a CAGR of 6.15% over the forecast period. Key factors estimated to drive the market growth are presence of a high target population, increasing prevalence of chronic diseases, and rising healthcare awareness. For instance, according to Down to Earth organization, as of December 2021, India has 74.2 million diabetic patients aged 20 - 79. Moreover, the number is expected to increase to 124.8 million by 2045. Furthermore, medical tourism in this nation is increasing, which in turn increases the number of surgeries performed. In addition, continued innovation, emphasis on affordability, and strategic collaborations within the industry were key aspects driving the growth of the market in India.
The wound care industry is highly fragmented in nature with the presence of several small and large manufacturers. Competitive rivalry and a degree of competition in the market are expected to intensify over the forecast period due to the presence of many players in the market. Companies in this market invest heavily in research and development to introduce new and innovative products. Advanced wound dressings, bioactive dressings, and novel technologies are areas of focus for differentiation. Key players often have diverse product portfolios covering a range of wound care products, including dressings, bandages, topical agents, and devices. This diversity allows companies to address various aspects of wound management.
Companies invest in adopting and integrating cutting-edge technologies, such as smart dressings, 3D printing, and telemedicine solutions. Technological leadership is expected to be a significant differentiator.The competitive rivalry in the market is likely to persist as companies strive to differentiate themselves and meet the evolving needs of healthcare providers and patients. Keeping abreast of technological advancements, regulatory changes, and market trends is crucial for sustained competitiveness in this dynamic industry.
The following are the leading companies in the wound care market. These companies collectively hold the largest market share and dictate industry trends. Financials, strategy maps & products of these wound care companies are analyzed to map the supply network.
In June 2023, an Evonik company-JeNaCell-introduced the wound dressing epicite balance to the German market. This dressing is well-suited and optimized for pressure ulcers, venous leg ulcers, arterial leg ulcers, diabetic foot ulcers, and soft tissue lesions, which are chronic wounds with low to medium exudation.
In March 2023, ConvaTec Group PLC announced the U.S. FDA’s approval of InnovaBurn placental extracellular matrix medical device for the treatment of difficult surgical wounds and burns.
In January 2023, Convatec launched the ConvaFoam in the U.S. ConvaFoam is a family of advanced foam dressings designed to meet the demands of medical professionals and their patients. This helped the company strengthen its presence in the U.S. market.
Report Attribute |
Details |
Market size value in 2024 |
USD 23.14 billion |
Revenue forecast in 2030 |
USD 29.57 billion |
Growth rate |
CAGR of 4.17% from 2024 to 2030 |
Base year for estimation |
2023 |
Actual data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, application, end-use, mode of purchase, distribution channel, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA) |
Country scope |
U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
Smith & Nephew; Mölnlycke Health Care AB; Convatec Group PLC; Ethicon (Johnson & Johnson); Baxter International; DeRoyal Industries, Inc.; Coloplast Corp.; Medtronic; 3M; Integra LifeSciences, Inc.; Medline Industries, Inc.; B. Braun Melsungen AG; Cardinal Health, Inc.; Organogenesis Inc.; MIMEDX Group, Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global wound care market report based on product, application, end-use, mode of purchase, distribution channel and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Advanced Wound Dressing
Foam Dressings
Hydrocolloid Dressings
Film Dressings
Alginate Dressings
Hydrogel Dressings
Collagen Dressings
Other Advanced Dressings
Surgical Wound Care
Sutures & staples
Tissue adhesive and sealants
Anti-infective dressing
Traditional Wound Care
Medical Tapes
Cotton
Bandages
Gauzes
Sponges
Cleansing Agents
Wound Therapy Devices
Negative pressure wound therapy
Oxygen and hyperbaric oxygen equipment
Electric stimulation devices
Pressure relief devices
Others
Application Outlook (Revenue, USD Million, 2018 - 2030)
Chronic Wounds
Diabetic foot ulcers
Pressure ulcers
Venous leg ulcers
Other chronic wounds
Acute Wounds
Surgical & traumatic wounds
Burns
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Specialty Clinics
Home Healthcare
Physician’s Office
Nursing Homes
Others
Mode of Purchase Outlook (Revenue, USD Million, 2018 - 2030)
Prescribed
Non-prescribed (OTC)
Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
Institutional Sales
Retail Sales
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. The global wound care market size was estimated at USD 22.25 billion in 2023 and is expected to reach USD 23.14 billion in 2024.
b. The global wound care market is expected to grow at a compound annual growth rate of 4.17% from 2024 to 2030 to reach USD 29.57 billion by 2030.
b. Advanced wound dressing dominated the wound care market in 2023 with a market share of 34.8% and is expected to witness the fastest growth over the forecast period due to an increase in technological advancement, rising cases of chronic diseases, and an increase in the number of sports-related injuries.
b. Some key players operating in the wound care market include Smith & Nephew PLC, Mölnlycke Health Care AB, ConvaTec Group PLC, Ethicon (Johnson & Johnson), Baxter International, URGO Medical, Coloplast Corp., Medtronic, 3M, and Derma Sciences, (Integra LifeSciences)
b. An aging population drives the wound care market, rising incidence of chronic diseases such as diabetes, increasing prevalence of pressure ulcers and venous leg ulcers, and growing demand for advanced wound care products and therapies. Technological advancements in wound care products, increasing awareness about wound care management, and favorable reimbursement policies are also contributing to market growth.
Table of Contents
Chapter 1. Wound Care Market: Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. End-use
1.1.4. Mode of purchase
1.1.5. Distribution channel
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Wound Care Market: Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Mode of purchase outlook
2.2.5. Distribution channel outlook
2.3. Competitive Insights
Chapter 3. Wound Care Market: Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. User Perspective Analysis
3.3. Covid-19 Impact Analysis
3.4. Trend of Self-medication
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
3.5.1.2. Rising incidence of burn injuries
3.5.1.3. Introduction of innovative and advanced wound products
3.5.1.4. Rising geriatric population
3.5.1.5. Increasing number of ambulatory surgical centers (ASCs)
3.5.1.6. Increasing number of road accidents
3.5.1.7. Steep rise in the number of hospitals & urgent care centers and an increase in hospital admissions
3.5.2. Market restraint analysis
3.5.2.1. Stringent manufacturing policies
3.5.2.2. High cost of advanced wound care products and chronic wound treatments
3.5.2.3. Delayed diagnosis and lower treatment rates in emerging nations
3.5.3. Market opportunity analysis
3.5.3.1. Improvements in public and private hospital infrastructure
3.5.3.2. Growth potential in emerging economies in wound care market
3.5.3.3. Leveraging digital platforms and telemedicine in wound care market
3.5.4. Market challenge analysis
3.5.4.1. Growing instances of product recalls
3.5.4.2. Lack of awareness about proper wound care practices and available treatment options
3.6. U.S. Wound Care Market Analysis Tools
3.6.1. Industry Analysis - Porter’s
3.6.1.1. Supplier power
3.6.1.2. Buyer power
3.6.1.3. Substitution threat
3.6.1.4. Threat of new entrant
3.6.1.5. Competitive rivalry
3.6.2. PESTEL Analysis
3.6.2.1. Political landscape
3.6.2.2. Economic landscape
3.6.2.3. Social landscape
3.6.2.4. Technological landscape
3.6.2.5. Environmental landscape
3.6.2.6. Legal landscape
Chapter 4. Wound Care Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Advanced wound dressing
4.1.2. Surgical wound care
4.1.3. Traditional wound care
4.1.4. Wound therapy devices
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Wound Care Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
4.5.1. Advanced wound dressing
4.5.1.1. Advanced wound dressing market estimates and forecast 2018 - 2030 (USD Million)
4.5.1.2. Foam dressings
4.5.1.2.1. Foam dressings market estimates and forecast 2018 - 2030 (USD Million)
4.5.1.3. Hydrocolloid dressings
4.5.1.3.1. Hydrocolloid dressings market estimates and forecast 2018 - 2030 (USD Million)
4.5.1.4. Film dressings
4.5.1.4.1. Film dressings market estimates and forecast 2018 - 2030 (USD Million)
4.5.1.5. Alginate dressings
4.5.1.5.1. Alginate dressings market estimates and forecast 2018 - 2030 (USD Million)
4.5.1.6. Hydrogel dressings
4.5.1.6.1. Hydrogel dressings market estimates and forecast 2018 - 2030 (USD Million)
4.5.1.7. Collagen dressings
4.4.1.7.1. Collagen dressings market estimates and forecast 2018 - 2030 (USD Million)
4.5.1.8. Other advanced dressings
4.5.1.8.1. Other advanced dressings market estimates and forecast 2018 - 2030 (USD Million)
4.5.2. Surgical wound care
4.5.2.1. Surgical wound care market estimates and forecast 2018 - 2030 (USD Million)
4.5.2.2. Sutures & staples
4.5.2.2.1. Sutures & staples market estimates and forecast 2018 - 2030 (USD Million)
4.5.2.3. Tissue adhesives & sealants
4.5.2.3.1. Tissue adhesives & sealants market estimates and forecast 2018 - 2030 (USD Million)
4.5.2.4. Anti-infective dressing
4.5.2.4.1. Anti-infective dressing market estimates and forecast 2018 - 2030 (USD Million)
4.5.3. Traditional wound care
4.5.3.1. Traditional wound care market estimates and forecast 2018 - 2030s, (USD Million)
4.5.3.2. Medical tapes
4.5.3.2.1. Medical tapes market estimates and forecast 2018 - 2030 (USD Million)
4.5.3.3. Cotton
4.5.3.3.1. Cotton market estimates and forecast 2018 - 2030 (USD Million)
4.5.3.4. Bandages
4.5.3.4.1. Bandages market estimates and forecast 2018 - 2030 (USD Million)
4.5.3.5. Gauzes
4.5.3.5.1. Gauzes market estimates and forecast 2018 - 2030 (USD Million)
4.5.3.6. Sponges
4.5.3.6.1. Sponges market estimates and forecast 2018 - 2030 (USD Million)
4.5.3.7. Cleansing agents
4.5.3.7.1. Cleansing agents market estimates and forecast 2018 - 2030 (USD Million)
4.5.4. Wound therapy devices
4.5.4.1. Wound therapy devices market estimates and forecast 2018 - 2030s, (USD Million)
4.5.4.2. Negative pressure wound therapy
4.5.4.2.1. Negative pressure wound therapy market estimates and forecast 2018 - 2030 (USD Million)
4.5.4.3. Oxygen and hyperbaric oxygen equipment
4.5.4.3.1. Oxygen and hyperbaric oxygen equipment market estimates and forecast 2018 - 2030 (USD Million)
4.5.4.4. Electric stimulation devices
4.5.4.4.1. Electric stimulation devices market estimates and forecast 2018 - 2030 (USD Million)
4.5.4.5. Pressure relief devices
4.5.4.5.1. Pressure relief devices market estimates and forecast 2018 - 2030 (USD Million)
4.5.4.6. Others
4.5.4.6.1. Others market estimates and forecast 2018 - 2030 (USD Million)
Chapter 5. Wound Care Market: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Acute Wounds
5.1.2. Chronic Wounds
5.2. Application Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. Wound Care Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
5.5.1. Acute Wounds
5.5.1.1. Acute wounds market estimates and forecast 2018 - 2030 (USD Million)
5.5.1.2. Surgical & traumatic wounds
5.5.1.2.1. Surgical & traumatic wounds market estimates and forecast 2018 - 2030 (USD Million)
5.5.1.3. Burns
5.5.1.3.1. Burns market estimates and forecast 2018 - 2030 (USD Million)
5.5.2. Chronic Wounds
5.5.2.1. Chronic wounds market estimates and forecast 2018 - 2030 (USD Million)
5.5.2.2. Diabetic foot ulcers
5.5.2.2.1. Diabetic foot ulcers market estimates and forecast 2018 - 2030 (USD Million)
5.5.2.3. Pressure ulcers
5.5.2.3.1. Pressure ulcers market estimates and forecast 2018 - 2030 (USD Million)
5.5.2.4. Venous leg ulcers
5.5.2.4.1. Venous leg ulcers market estimates and forecast 2018 - 2030 (USD Million)
5.5.2.5. Others chronic wounds
5.5.2.5.1. Others chronic wounds market estimates and forecast 2018 - 2030 (USD Million)
Chapter 6. Wound Care Devices: End-use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Specialty clinics
6.1.3. Home healthcare
6.1.4. Physician’s office
6.1.5. Nursing homes
6.1.6. Others
6.2. End-use Market Share, 2018 & 2030
6.3. Segment Dashboard
6.4. Wound Care Market by End-use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
6.5.1. Hospitals
6.5.1.1. Hospitals market estimates and forecast 2018 - 2030 (USD Million)
6.5.2. Specialty clinics
6.5.2.1. Specialty clinics centers market estimates and forecast 2018 - 2030 (USD Million)
6.5.3. Home healthcare
6.5.3.1. Home healthcare market estimates and forecast 2018 - 2030 (USD Million)
6.5.4. Physician’s office
6.5.4.1. Physician’s office market estimates and forecast 2018 - 2030 (USD Million)
6.5.5. Nursing Homes
6.5.5.1. Nursing homes market estimates and forecast 2018 - 2030 (USD Million)
6.5.6. Others
6.5.6.1. Others market estimates and forecast 2018 - 2030 (USD Million)
Chapter 7. Wound Care Market: Mode of Purchase Estimates & Trend Analysis
7.1. Definitions and Scope
7.1.1. Prescribed
7.1.2. Non-prescribed (OTC)
7.2. Mode of Purchase Market Share, 2018 & 2030
7.3. Segment Dashboard
7.4. Wound Care Market by Mode of Purchase Outlook
7.5. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
7.5.1. Prescribed
7.5.1.1. Prescribed market estimates and forecast 2018 - 2030 (USD Million)
7.5.2. Non-prescribed (OTC)
7.5.2.1. Non-prescribed (OTC) market estimates and forecast 2018 - 2030 (USD Million)
Chapter 8. Wound Care Market: Distribution Channel Estimates & Trend Analysis
8.1. Definitions and Scope
8.1.1. Institutional sales
8.1.2. Retail sales
8.2. Distribution Channel Market Share, 2018 & 2030
8.3. Segment Dashboard
8.4. Wound Care Market by Distribution Channel Outlook
8.5. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
8.5.1. Institutional sales
8.5.1.1. Institutional sales market estimates and forecast 2018 - 2030 (USD Million)
8.5.2. Retail sales
8.5.2.1. Retail sales market estimates and forecast 2018 - 2030 (USD Million)
Chapter 9. Wound Care Market: Regional Estimates & Trend Analysis
9.1. Regional market share analysis, 2023 & 2030
9.2. Regional Market Dashboard
9.3. Global Regional Market Snapshot
9.4. Market Application, & Forecasts and Trend Analysis, 2018 - 2030
9.5. North America
9.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
9.5.2. U.S.
9.5.2.1. Key country dynamics
9.5.2.2. Competitive scenario
9.5.2.3. Regulatory framework
9.5.2.4. Reimbursement scenario
9.5.2.5. U.S. market estimates and forecasts, 2018 - 2030
9.5.3. Canada
9.5.3.1. Key country dynamics
9.5.3.2. Competitive scenario
9.5.3.3. Regulatory framework
9.5.3.4. Reimbursement scenario
9.5.3.5. Canada market estimates and forecasts, 2018 - 2030¬
9.6. Europe
9.6.1. UK
9.6.1.1. Key country dynamics
9.6.1.2. Competitive scenario
9.6.1.3. Regulatory framework
9.6.1.4. Reimbursement scenario
9.6.1.5. UK market estimates and forecasts, 2018 - 2030
9.6.2. Germany
9.6.2.1. Key country dynamics
9.6.2.2. Competitive scenario
9.6.2.3. Regulatory framework
9.6.2.4. Reimbursement scenario
9.6.2.5. Germany market estimates and forecasts, 2018 - 2030
9.6.3. France
9.6.3.1. Key country dynamics
9.6.3.2. Competitive scenario
9.6.3.3. Regulatory framework
9.6.3.4. Reimbursement scenario
9.6.3.5. France market estimates and forecasts, 2018 - 2030
9.6.4. Italy
9.6.4.1. Key country dynamics
9.6.4.2. Competitive scenario
9.6.4.3. Regulatory framework
9.6.4.4. Reimbursement scenario
9.6.4.5. Italy market estimates and forecasts, 2018 - 2030
9.6.5. Spain
9.6.5.1. Key country dynamics
9.6.5.2. Competitive scenario
9.6.5.3. Regulatory framework
9.6.5.4. Reimbursement scenario
9.6.5.5. Spain market estimates and forecasts, 2018 - 2030
9.6.6. Denmark
9.6.6.1. Key country dynamics
9.6.6.2. Competitive scenario
9.6.6.3. Regulatory framework
9.6.6.4. Reimbursement scenario
9.6.6.5. Denmark market estimates and forecasts, 2018 - 2030
9.6.7. Sweden
9.6.7.1. Key country dynamics
9.6.7.2. Competitive scenario
9.6.7.3. Regulatory framework
9.6.7.4. Reimbursement scenario
9.6.7.5. Sweden market estimates and forecasts, 2018 - 2030
9.6.8. Norway
9.6.8.1. Key country dynamics
9.6.8.2. Competitive scenario
9.6.8.3. Regulatory framework
9.6.8.4. Reimbursement scenario
9.6.8.5. Norway market estimates and forecasts, 2018 - 2030
9.7. Asia Pacific
9.7.1. Japan
9.7.1.1. Key country dynamics
9.7.1.2. Competitive scenario
9.7.1.3. Regulatory framework
9.7.1.4. Reimbursement scenario
9.7.1.5. Japan market estimates and forecasts, 2018 - 2030
9.7.2. India
9.7.2.1. Key country dynamics
9.7.2.2. Competitive scenario
9.7.2.3. Regulatory framework
9.7.2.4. Reimbursement scenario
9.7.2.5. India market estimates and forecasts, 2018 - 2030
9.7.3. China
9.7.3.1. Key country dynamics
9.7.3.2. Competitive scenario
9.7.3.3. Regulatory framework
9.7.3.4. Reimbursement scenario
9.7.3.5. China market estimates and forecasts, 2018 - 2030
9.7.4. South Korea
9.7.4.1. Key country dynamics
9.7.4.2. Competitive scenario
9.7.4.3. Regulatory framework
9.7.4.4. Reimbursement scenario
9.7.4.5. South Korea market estimates and forecasts, 2018 - 2030
9.7.5. Australia
9.7.5.1. Key country dynamics
9.7.5.2. Competitive scenario
9.7.5.3. Regulatory framework
9.7.5.4. Reimbursement scenario
9.7.5.5. Australia market estimates and forecasts, 2018 - 2030
9.7.6. Thailand
9.7.6.1. Key country dynamics
9.7.6.2. Competitive scenario
9.7.6.3. Regulatory framework
9.7.6.4. Reimbursement scenario
9.7.6.5. Thailand market estimates and forecasts, 2018 - 2030
9.8. Latin America
9.8.1. Brazil
9.8.1.1. Key country dynamics
9.8.1.2. Competitive scenario
9.8.1.3. Regulatory framework
9.8.1.4. Reimbursement scenario
9.8.1.5. Brazil market estimates and forecasts, 2018 - 2030
9.8.2. Mexico
9.8.2.1. Key country dynamics
9.8.2.2. Competitive scenario
9.8.2.3. Regulatory framework
9.8.2.4. Reimbursement scenario
9.8.2.5. Mexico market estimates and forecasts, 2018 - 2030
9.8.3. Argentina
9.8.3.1. Key country dynamics
9.8.3.2. Competitive scenario
9.8.3.3. Regulatory framework
9.8.3.4. Reimbursement scenario
9.8.3.5. Argentina market estimates and forecasts, 2018 - 2030
9.9. MEA
9.9.1. South Africa
9.9.1.1. Key country dynamics
9.9.1.2. Competitive scenario
9.9.1.3. Regulatory framework
9.9.1.4. Reimbursement scenario
9.9.1.5. South Africa market estimates and forecasts, 2018 - 2030
9.9.2. Saudi Arabia
9.9.2.1. Key country dynamics
9.9.2.2. Competitive scenario
9.9.2.3. Regulatory framework
9.9.2.4. Reimbursement scenario
9.9.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
9.9.3. UAE
9.9.3.1. Key country dynamics
9.9.3.2. Competitive scenario
9.9.3.3. Regulatory framework
9.9.3.4. Reimbursement scenario
9.9.3.5. UAE market estimates and forecasts, 2018 - 2030
9.9.4. Kuwait
9.9.4.1. Key country dynamics
9.9.4.2. Competitive scenario
9.9.4.3. Regulatory framework
9.9.4.4. Reimbursement scenario
9.9.4.5. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.2.1. Innovators
10.3. Vendor Landscape
10.3.1. List of key distributors and channel partners
10.3.2. Key customers
10.3.3. Key company market share analysis, 2023
10.3.4. Smith & Nephew
10.3.4.1. Company overview
10.3.4.2. Financial performance
10.3.4.3. Product benchmarking
10.3.4.4. Strategic initiatives
10.3.5. Mölnlycke Health Care AB
10.3.5.1. Company overview
10.3.5.2. Financial performance
10.3.5.3. Product benchmarking
10.3.5.4. Strategic initiatives
10.3.6. ConvaTec Group PLC
10.3.6.1. Company overview
10.3.6.2. Financial performance
10.3.6.3. Product benchmarking
10.3.6.4. Strategic initiatives
10.3.7. Ethicon (Johnson & Johnson)
10.3.7.1. Company overview
10.3.7.2. Financial performance
10.3.7.3. Product benchmarking
10.3.7.4. Strategic initiatives
10.3.8. Baxter International
10.3.8.1. Company overview
10.3.8.2. Financial performance
10.3.8.3. Product benchmarking
10.3.8.4. Strategic initiatives
10.3.9. DeRoyal Industries, Inc.
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Product benchmarking
10.3.9.4. Strategic initiatives
10.3.10. Coloplast Corp.
10.3.10.1. Company overview
10.3.10.2. Financial performance
10.3.10.3. Product benchmarking
10.3.10.4. Strategic initiatives
10.3.11. Medtronic
10.3.11.1. Company overview
10.3.11.2. Financial performance
10.3.11.3. Product benchmarking
10.3.11.4. Strategic initiatives
10.3.12. 3M
10.3.12.1. Company overview
10.3.12.2. Financial performance
10.3.12.3. Product benchmarking
10.3.12.4. Strategic initiatives
10.3.13. Integra LifeSciences, Inc.
10.3.13.1. Company overview
10.3.13.2. Financial performance
10.3.13.3. Product benchmarking
10.3.13.4. Strategic initiatives
10.3.14. Medline Industries, Inc.
10.3.14.1. Company overview
10.3.14.2. Financial performance
10.3.14.3. Product benchmarking
10.3.14.4. Strategic initiatives
10.3.15. B. Braun Melsungen AG
10.3.15.1. Company overview
10.3.15.2. Financial performance
10.3.15.3. Product benchmarking
10.3.15.4. Strategic initiatives
10.3.16. Cardinal Health, Inc.
10.3.16.1. Company overview
10.3.16.2. Financial performance
10.3.16.3. Product benchmarking
10.3.16.4. Strategic initiatives
10.3.17. Organogenesis Inc.
10.3.17.1. Company overview
10.3.17.2. Financial performance
10.3.17.3. Product benchmarking
10.3.17.4. Strategic initiatives
10.3.18. MIMEDX Group, Inc.
10.3.18.1. Company overview
10.3.18.2. Financial performance
10.3.18.3. Product benchmarking
10.3.18.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America wound care market, by country, 2018 - 2030 (USD Million)
Table 4 North America wound care market, by product, 2018 - 2030 (USD Million)
Table 5 North America wound care market, by application, 2018 - 2030 (USD Million)
Table 6 North America wound care market, by end-use, 2018 - 2030 (USD Million)
Table 7 North America wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 8 North America wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 9 US wound care market, by product, 2018 - 2030 (USD Million)
Table 10 US wound care market, by application, 2018 - 2030 (USD Million)
Table 11 US wound care market, by end-use, 2018 - 2030 (USD Million)
Table 12 US wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 13 US wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 14 Canada wound care market, by product, 2018 - 2030 (USD Million)
Table 15 Canada wound care market, by application, 2018 - 2030 (USD Million)
Table 16 Canada wound care market, by end-use, 2018 - 2030 (USD Million)
Table 17 Canada wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 18 Canada wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 19 Europe wound care market, by country, 2018 - 2030 (USD Million)
Table 20 Europe wound care market, by product, 2018 - 2030 (USD Million)
Table 21 Europe wound care market, by application, 2018 - 2030 (USD Million)
Table 22 Europe wound care market, by end-use, 2018 - 2030 (USD Million)
Table 23 Europe wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 24 Europe wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 25 UK wound care market, by product, 2018 - 2030 (USD Million)
Table 26 UK wound care market, by application, 2018 - 2030 (USD Million)
Table 27 UK wound care market, by end-use, 2018 - 2030 (USD Million)
Table 28 UK wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 29 UK wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 30 Germany wound care market, by product, 2018 - 2030 (USD Million)
Table 31 Germany wound care market, by application, 2018 - 2030 (USD Million)
Table 32 Germany wound care market, by end-use, 2018 - 2030 (USD Million)
Table 33 Germany wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 34 Germany wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 35 France wound care market, by product, 2018 - 2030 (USD Million)
Table 36 France wound care market, by application, 2018 - 2030 (USD Million)
Table 37 France wound care market, by end-use, 2018 - 2030 (USD Million)
Table 38 France wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 39 France wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 40 Italy wound care market, by product, 2018 - 2030 (USD Million)
Table 41 Italy wound care market, by application, 2018 - 2030 (USD Million)
Table 42 Italy wound care market, by end-use, 2018 - 2030 (USD Million)
Table 43 Italy wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 44 Italy wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 45 Spain wound care market, by product, 2018 - 2030 (USD Million)
Table 46 Spain wound care market, by application, 2018 - 2030 (USD Million)
Table 47 Spain wound care market, by end-use, 2018 - 2030 (USD Million)
Table 48 Spain wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 49 Spain wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 50 Denmark wound care market, by product, 2018 - 2030 (USD Million)
Table 51 Denmark wound care market, by application, 2018 - 2030 (USD Million)
Table 52 Denmark wound care market, by end-use, 2018 - 2030 (USD Million)
Table 53 Denmark wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 54 Denmark wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 55 Sweden wound care market, by product, 2018 - 2030 (USD Million)
Table 56 Sweden wound care market, by application, 2018 - 2030 (USD Million)
Table 57 Sweden wound care market, by end-use, 2018 - 2030 (USD Million)
Table 58 Sweden wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 59 Sweden wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 60 Norway wound care market, by product, 2018 - 2030 (USD Million)
Table 61 Norway wound care market, by application, 2018 - 2030 (USD Million)
Table 62 Norway wound care market, by end-use, 2018 - 2030 (USD Million)
Table 63 Norway wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 64 Norway wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 65 Asia Pacific wound care market, by country, 2018 - 2030 (USD Million)
Table 66 Asia Pacific wound care market, by product, 2018 - 2030 (USD Million)
Table 67 Asia Pacific wound care market, by application, 2018 - 2030 (USD Million)
Table 68 Asia Pacific wound care market, by end-use, 2018 - 2030 (USD Million)
Table 69 Asia Pacific wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 70 Asia Pacific wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 71 China wound care market, by product, 2018 - 2030 (USD Million)
Table 72 China wound care market, by application, 2018 - 2030 (USD Million)
Table 73 China wound care market, by end-use, 2018 - 2030 (USD Million)
Table 74 China wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 75 China wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 76 Japan wound care market, by product, 2018 - 2030 (USD Million)
Table 77 Japan wound care market, by application, 2018 - 2030 (USD Million)
Table 78 Japan wound care market, by end-use, 2018 - 2030 (USD Million)
Table 79 Japan wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 80 Japan wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 81 India wound care market, by product, 2018 - 2030 (USD Million)
Table 82 India wound care market, by application, 2018 - 2030 (USD Million)
Table 83 India wound care market, by end-use, 2018 - 2030 (USD Million)
Table 84 India wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 85 India wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 86 South Korea wound care market, by product, 2018 - 2030 (USD Million)
Table 87 South Korea wound care market, by application, 2018 - 2030 (USD Million)
Table 88 South Korea wound care market, by end-use, 2018 - 2030 (USD Million)
Table 89 South Korea wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 90 South Korea wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 91 Australia wound care market, by product, 2018 - 2030 (USD Million)
Table 92 Australia wound care market, by application, 2018 - 2030 (USD Million)
Table 93 Australia wound care market, by end-use, 2018 - 2030 (USD Million)
Table 94 Australia wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 95 Australia wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 96 Thailand wound care market, by product, 2018 - 2030 (USD Million)
Table 97 Thailand wound care market, by application, 2018 - 2030 (USD Million)
Table 98 Thailand wound care market, by end-use, 2018 - 2030 (USD Million)
Table 99 Thailand wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 100 Thailand wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 101 Latin America wound care market, by country, 2018 - 2030 (USD Million)
Table 102 Latin America wound care market, by product, 2018 - 2030 (USD Million)
Table 103 Latin America wound care market, by application, 2018 - 2030 (USD Million)
Table 104 Latin America wound care market, by end-use, 2018 - 2030 (USD Million)
Table 105 Latin America wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 106 Latin America wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 107 Brazil wound care market, by product, 2018 - 2030 (USD Million)
Table 108 Brazil wound care market, by application, 2018 - 2030 (USD Million)
Table 109 Brazil wound care market, by end-use, 2018 - 2030 (USD Million)
Table 110 Brazil wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 111 Brazil wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 112 Mexico wound care market, by product, 2018 - 2030 (USD Million)
Table 113 Mexico wound care market, by application, 2018 - 2030 (USD Million)
Table 114 Mexico wound care market, by end-use, 2018 - 2030 (USD Million)
Table 115 Mexico wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 116 Mexico wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 117 Argentina wound care market, by product, 2018 - 2030 (USD Million)
Table 118 Argentina wound care market, by application, 2018 - 2030 (USD Million)
Table 119 Argentina wound care market, by end-use, 2018 - 2030 (USD Million)
Table 120 Argentina wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 121 Argentina wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 122 Middle East & Africa wound care market, by country, 2018 - 2030 (USD Million)
Table 123 Middle East & Africa wound care market, by product, 2018 - 2030 (USD Million)
Table 124 Middle East & Africa wound care market, by application, 2018 - 2030 (USD Million)
Table 125 Middle East & Africa wound care market, by end-use, 2018 - 2030 (USD Million)
Table 126 Middle East & Africa wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 127 Middle East & Africa wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 128 South Africa wound care market, by product, 2018 - 2030 (USD Million)
Table 129 South Africa wound care market, by application, 2018 - 2030 (USD Million)
Table 130 South Africa wound care market, by end-use, 2018 - 2030 (USD Million)
Table 131 South Africa wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 132 South Africa wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 133 Saudi Arabia wound care market, by product, 2018 - 2030 (USD Million)
Table 134 Saudi Arabia wound care market, by application, 2018 - 2030 (USD Million)
Table 135 Saudi Arabia wound care market, by end-use, 2018 - 2030 (USD Million)
Table 136 Saudi Arabia wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 137 Saudi Arabia wound care market, by distribution channel, 2018 - 2030 (USD Million)¬
Table 138 UAE wound care market, by product, 2018 - 2030 (USD Million)
Table 139 UAE wound care market, by application, 2018 - 2030 (USD Million)
Table 140 UAE wound care market, by end-use, 2018 - 2030 (USD Million)
Table 141 UAE wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 142 UAE wound care market, by distribution channel, 2018 - 2030 (USD Million)
Table 143 Kuwait wound care market, by product, 2018 - 2030 (USD Million)
Table 144 Kuwait wound care market, by application, 2018 - 2030 (USD Million)
Table 145 Kuwait wound care market, by end-use, 2018 - 2030 (USD Million)
Table 146 Kuwait wound care market, by mode of purchase, 2018 - 2030 (USD Million)
Table 147 Kuwait wound care market, by distribution channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Wound care market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2023)
Fig. 10 Segment outlook
Fig. 11 Strategy framework
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Consumer behavior analysis
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Market restraint opportunity analysis (Current & future impact)
Fig. 17 Market restraint challenge analysis (Current & future impact)
Fig. 18 Porter’s five forces analysis
Fig. 19 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 20 Wound care market: Product movement analysis
Fig. 21 Wound care market Product outlook: Key takeaways
Fig. 22 Advanced wound dressing market, 2018 - 2030 (USD Million)
Fig. 23 Foam dressing market, 2018 - 2030 (USD Million)
Fig. 24 Hydrocolloid dressing market, 2018 - 2030 (USD Million)
Fig. 25 Film dressing market, 2018 - 2030 (USD Million)
Fig. 26 Alginate dressing market, 2018 - 2030 (USD Million)
Fig. 27 Hydrogel dressing market, 2018 - 2030 (USD Million)
Fig. 28 Collagen dressing market, 2018 - 2030 (USD Million)
Fig. 29 Other advanced wound dressing market, 2018 - 2030 (USD Million)
Fig. 30 Surgical wound care market, 2018 - 2030 (USD Million)
Fig. 31 Sutures & staples market, 2018 - 2030 (USD Million)
Fig. 32 Tissue adhesives and sealants market, 2018 - 2030 (USD Million)
Fig. 33 Anti-infective dressing market, 2018 - 2030 (USD Million)
Fig. 34 Traditional wound dressing market, 2018 - 2030 (USD Million)
Fig. 35 Medical tapes market, 2018 - 2030 (USD Million)
Fig. 36 Cotton market, 2018 - 2030 (USD Million)
Fig. 37 Bandages market, 2018 - 2030 (USD Million)
Fig. 38 Gauzes market, 2018 - 2030 (USD Million)
Fig. 39 Sponges market, 2018 - 2030 (USD Million)
Fig. 40 Cleansing agents market, 2018 - 2030 (USD Million)
Fig. 41 Wound therapy devices market, 2018 - 2030 (USD Million)
Fig. 42 Negative pressure wound therapy market, 2018 - 2030 (USD Million)
Fig. 43 Oxygen and hyperbaric oxygen equipment market, 2018 - 2030 (USD Million)
Fig. 44 Electric stimulation devices market, 2018 - 2030 (USD Million)
Fig. 45 Pressure relief devices market, 2018 - 2030 (USD Million)
Fig. 46 Others market, 2018 - 2030 (USD Million)
Fig. 47 Wound care market: End-use movement analysis
Fig. 48 Hospital market, 2018 - 2030 (USD Million)
Fig. 49 Specialty clinics market, 2018 -- 2030 (USD Million)
Fig. 50 Home healthcare market, 2018 - 2030 (USD Million)
Fig. 51 Physician’s office market, 2018 - 2030 (USD Million)
Fig. 52 Nursing homes market, 2018 - 2030 (USD Million)
Fig. 53 Others market, 2018 - 2030 (USD Million)
Fig. 54 Wound care market: Mode of purchase movement analysis
Fig. 55 Prescribed market, 2018 - 2030 (USD Million)
Fig. 56 Non-prescribed (OTC) market, 2018 -- 2030 (USD Million)
Fig. 57 Wound care market: Distribution channel movement analysis
Fig. 58 Institutional sales market, 2018 - 2030 (USD Million)
Fig. 59 Retail sales market, 2018 -- 2030 (USD Million)
Fig. 60 Wound care market: Application movement analysis
Fig. 61 Wound care market application outlook: Key takeaways
Fig. 62 Chronic wounds market, 2018 - 2030 (USD Million)
Fig. 63 Diabetic foot ulcers market, 2018 - 2030 (USD Million)
Fig. 64 Pressure ulcers market, 2018 - 2030 (USD Million)
Fig. 65 Venous leg ulcers market, 2018 - 2030 (USD Million)
Fig. 66 Other chronic wounds market, 2018 - 2030 (USD Million)
Fig. 67 Acute wounds market, 2018 - 2030 (USD Million)
Fig. 68 Surgical & traumatic wounds market, 2018 - 2030 (USD Million)
Fig. 69 Burns market, 2018 - 2030 (USD Million)
Fig. 70 Regional outlook, 2023 & 2030
Fig. 71 Regional market place: Key takeaways
Fig. 72 North America wound care market, 2018 - 2030 (USD Million)
Fig. 73 US wound care market, 2018 - 2030 (USD Million)
Fig. 74 Canada wound care market, 2018 - 2030 (USD Million)
Fig. 75 Europe wound care market, 2018 - 2030 (USD Million)
Fig. 76 UK wound care market, 2018 - 2030 (USD Million)
Fig. 77 Germany wound care market, 2018 - 2030 (USD Million)
Fig. 78 France wound care market, 2018 - 2030 (USD Million)
Fig. 79 Italy wound care market, 2018 - 2030 (USD Million)
Fig. 80 Spain wound care market, 2018 - 2030 (USD Million)
Fig. 81 Denmark wound care market, 2018 - 2030 (USD Million)
Fig. 82 Sweden wound care market, 2018 - 2030 (USD Million)
Fig. 83 Norway wound care market, 2018 - 2030 (USD Million)
Fig. 84 Asia Pacific wound care market, 2018 - 2030 (USD Million)
Fig. 85 Japan wound care market, 2018 - 2030 (USD Million)
Fig. 86 China wound care market, 2018 - 2030 (USD Million)
Fig. 87 India wound care market, 2018 - 2030 (USD Million)
Fig. 88 South Korea wound care market, 2018 - 2030 (USD Million)
Fig. 89 Australia wound care market, 2018 - 2030 (USD Million)
Fig. 90 Thailand wound care market, 2018 - 2030 (USD Million)
Fig. 91 Latin America wound care market, 2018 - 2030 (USD Million)
Fig. 92 Brazil wound care market, 2018 - 2030 (USD Million)
Fig. 93 Mexico wound care market, 2018 - 2030 (USD Million)
Fig. 94 Argentina wound care market, 2018 - 2030 (USD Million)
Fig. 95 MEA wound care market, 2018 - 2030 (USD Million)
Fig. 96 South Africa wound care market, 2018 - 2030 (USD Million)
Fig. 97 Saudi Arabia wound care market, 2018 - 2030 (USD Million)
Fig. 98 UAE wound care market, 2018 - 2030 (USD Million)
Fig. 99 Kuwait wound care market, 2018 - 2030 (USD Million)
Market Segmentation
Increasing global prevalence of chronic diseases is a key factor driving the market growth. Factors such as antimicrobial resistance, unhealthy & sedentary lifestyles, and tobacco & alcohol consumption are contributing to the rising prevalence of non-communicable diseases. For instance, as per the WHO data published in September 2023, Noncommunicable Diseases (NCDs) kill 41 million people annually, corresponding to 74% of all deaths worldwide. Similarly, the CDC estimates that 6 in 10 adults in the U.S. currently live with a chronic disease such as cancer, heart disease, or diabetes. Moreover, according to the National Association of Chronic Disease Directors, 2022, nearly 60% of adult Americans have at least one chronic disease. According to CDC’s National Diabetes Statistics report of 2020, the number of diabetes patients has increased to an estimated 34.2 million. Such factors are expected to contribute to the market’s growth.
Technological advancements are projected to have a significant impact on advanced wound care industry in the coming years. The quality of life of patients suffering from chronic wounds improves as technology advances and becomes more affordable. Traditional wound care and closure products are gradually being replaced by advanced wound care & closure products due to their efficacy and effectiveness in wound management by allowing quicker healing. Advanced wound dressings are integrated with antimicrobial or wound healing agents that are 50% more effective, provides rapid healing, low infection rate and painless dressing removal. They also provide better cosmetic outcomes with less scarring, non-requirement of regular dressing changes leading to cost savings, leading to replacement of conventional wound dressings.
The U.S. FDA classifies most of the wound care products under Class I medical devices, which are exempted from premarket approval. Surgical dressings are used to cover open incision wounds; thus, these products must be free from any microbial contamination and must be manufactured in a sterile environment. Any form of microbial contamination may hinder the wound-healing process and, in extreme cases, may cause additional infection at the site. Thus, manufacturing companies may not need premarket approval, but they may be required to comply with the Good Manufacturing Practices (GMP). According to these policies, wound care products have to be manufactured under sterile conditions and ha undergo an extensive quality control process before launching products.
This section will provide insights into the contents included in this wound care market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
Company overview
Financial performance
Product benchmarking
Latest strategic developments
Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance
A three-pronged approach was followed for deducing the wound care market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:
Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for wound care market to gather the most reliable and current information possible.
Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of wound care market data depending on the type of information we’re trying to uncover in our research.
Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.
Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.
Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.
Qualitative Functional Deployment (QFD) Modelling for market share assessment.
Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.
Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.
Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.
This step also entails the finalization of the report scope and data representation pattern.
Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.
The wound care market was categorized into six segments, namely product (Advanced Wound Dressing, Surgical Wound Care, Traditional Wound Care, Wound Therapy Devices), application (Chronic Wounds, Acute Wounds), end-use (Hospitals, Specialty Clinics, Home Healthcare, Physician’s Office, Nursing Homes), mode of purchase (Prescribed, Non-prescribed), distribution channel (Institutional Sales, Retail Sales), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).
The wound care market was segmented into product, application, end-use, mode of purchase, distribution channel, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:
Demand estimation of each product across countries/regions summed up to from the total market.
Variable analysis for demand forecast.
Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.
Primary interviews for data revalidation and insight collection.
Used extensively for new product forecasting or analyzing penetration levels.
Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.
Primary interviews and vendor-based primary research for variable impact analysis.
The wound care market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.
All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.
The wound care market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:
Smith & Nephew plc: Smith & Nephew PLC is a medical technology company engaged in developing, manufacturing, marketing, and selling services & medical devices. It provides orthopedics, sports medicine & ENT, and advanced wound care management services. Under the wound care management segment, the company offers products for treating chronic and acute wounds, including diabetic ulcers, leg burns & postoperative wounds.
Mölnlycke Health Care AB: Mölnlycke Health Care AB is a medical solutions company that manufactures single-use wound and surgical care products. It designs & supplies medical solutions for pressure ulcer treatment, infection prevention, and wound treatment, including custom procedure trays, antiseptics, dental products, surgical gloves, surgical drapes, orthopedic products, dermatology products, & staff clothing.
ConvaTec Group PLC: ConvaTec Group PLC develops and manufactures medical devices & technologies for the management of chronic & acute conditions globally. The company offers products for advanced wound care, continence & critical care, ostomy care, and infusion devices. Its product range includes infection prevention, continence care, ostomy care, wound therapeutics, infusion devices, & critical care products to treat diabetes and other conditions.
Baxter International: Baxter International manufactures and distributes products & technologies related to infectious diseases, kidney disease, hemophilia, immune disorders, trauma, and other chronic & acute medical conditions. It offers products in pharmaceuticals, clinical nutrition, renal care, medication delivery, advanced surgery, and acute therapies. It specializes in medical devices, pharmacy automation, anesthetics, and biosurgery & wound care solutions.
DeRoyal Industries, Inc.: DeRoyal Industries, Inc. is a manufacturer of medical equipment with the goal of enhancing its clients’ financial stability and clinical quality. It offers orthopedic supports & bracing, wound care dressings, surgical instruments, medical unitized delivery systems, plastic injection molding, metal fabrication, converting, electronics assembly, sterilizing services, and other products & services.
Coloplast Corp.: Coloplast Corp. is a healthcare products and services company with a distribution network across 53 countries. Its product range includes ostomy, urology, continence, wound care, and skin care. The company primarily supplies its products to hospitals, pharmacies, wholesalers, and institutions. It also provides surgical devices for severe medical conditions, such as kidney stones, urinary incontinence, and enlarged prostate. Its key brands are Assura, InterDry, Titan, Aris, Self-Cath, SpeediCath, Biatain, Freedom Cath, and SenSura.
Medtronic: Medtronic is a global health solutions company engaged in developing, manufacturing, distributing, and commercializing device-based medical therapies & services. It operates through four reporting segments: minimally invasive therapies, cardiac & vascular, restorative therapies, and diabetes. The minimally invasive therapies segment includes mesh fixation devices; hardware instruments; and surgical products such as vessel sealing instruments, wound closure, stapling devices, electrosurgical products, & mesh implants.
3M: 3M develops, manufactures, and markets a range of products and services worldwide. The company functions across four reportable segments: transportation & electronics; safety & industrial; healthcare; and consumer. Its healthcare segment includes products and services, such as skin health & infection prevention products, oral care solutions, medical tapes & dressings, wound closure products, orthopedic casing materials, stethoscopes, and transdermal drug delivery systems. Its healthcare segment includes medical and surgical care.
Derma Sciences (Integra LifeSciences): Derma Sciences creates and sells medical technology solutions, including implant systems, electrosurgery units, surgical laser systems, sterilization containers, operating room lights, and surgical instruments.
Medline Industries, Inc.: Medline Industries, Inc. is a privately owned manufacturer and distributor of medical supplies to provide products, support & education. In 2017, the company acquired Centurion Medical Products. Centurion Medical Products is a manufacturer and supplier of medical devices. The company intends to provide quality-driven and solution-based health products manufactured considering rigorous standards. It provides dressings, trays, and single-use instruments, which help clinicians provide quality care.
Supply Side Estimates
Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.
Segment revenue determination via variable analysis and penetration modeling.
Competitive benchmarking to identify market leaders and their collective revenue shares.
Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.
Demand side estimates
Identifying parent markets and ancillary markets
Segment penetration analysis to obtain pertinent
revenue/volume
Heuristic forecasting with the help of subject matter experts
Forecasting via variable analysis
Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.
Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.
Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2022, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.
The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.
The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.
We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.
All market estimates and forecasts have been validated through primary interviews with the key industry participants.
Inflation has not been accounted for to estimate and forecast the market.
Numbers may not add up due to rounding off.
Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).
Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).
Latin America includes Central American countries and the South American continent
Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.
GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.
We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:
Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.
Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.
The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."